Skip to main content
. 2014 Jun 17;33(1):52. doi: 10.1186/1756-9966-33-52

Figure 1.

Figure 1

Anti-proliferative effects of AZD6244 and BEZ235 in NCI-H1993, NCI-H1975 and NCI-H460 gefitinib-resistant cell lines. Cells were treated with varying concentrations of AZD6244 (A) or BEZ235 (B) alone for 72 h. Doses ranged from 0.01 μM to 100 μM. Mean ± SD, n = 5.